Search

everythinglearnresearchcommunity

for

Search:↓

Some women with common hair loss may develop permanent hair loss.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Some people's hair loss is caused by multiple factors, with the most common being a mix of AGA and CCCA.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Early and aggressive treatment can significantly regrow hair in discoid lupus erythematosus.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Transverse scalp sections are better for diagnosing non-scarring hair loss, while vertical sections are better for a specific scarring hair loss called lichen planopilaris.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.